September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Profiles of cytokines in the aqueous humor and serum of bullous keratopathy patients
Author Affiliations & Notes
  • Morio Ueno
    Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan
  • Munetoyo Toda
    Department of Frontier Medical Science and Technology for Ophthalmology, Kyoto Prefectural university of Medicine, Kyoto, Japan
  • Asako Hiraga
    Department of Frontier Medical Science and Technology for Ophthalmology, Kyoto Prefectural university of Medicine, Kyoto, Japan
  • Koichi Wakimasu
    Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan
  • Noriko Koizumi
    Department of Biomedical Engineering, Faculty of Life and Medical Sciences, Doshisha University, Kyotanabe, Japan
  • Naoki Okumura
    Department of Biomedical Engineering, Faculty of Life and Medical Sciences, Doshisha University, Kyotanabe, Japan
  • Kazuko Asada
    Department of Frontier Medical Science and Technology for Ophthalmology, Kyoto Prefectural university of Medicine, Kyoto, Japan
  • Chie Sotozono
    Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan
  • Junji Hamuro
    Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan
  • Shigeru Kinoshita
    Department of Frontier Medical Science and Technology for Ophthalmology, Kyoto Prefectural university of Medicine, Kyoto, Japan
  • Footnotes
    Commercial Relationships   Morio Ueno, Santen Pharmaceutical Co. (P), Senju Pharmaceutical Co. (P); Munetoyo Toda, None; Asako Hiraga, None; Koichi Wakimasu, None; Noriko Koizumi, None; Naoki Okumura, None; Kazuko Asada, None; Chie Sotozono, None; Junji Hamuro, None; Shigeru Kinoshita, None
  • Footnotes
    Support  Highway Program for realization of regenerative medicine
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 898. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Morio Ueno, Munetoyo Toda, Asako Hiraga, Koichi Wakimasu, Noriko Koizumi, Naoki Okumura, Kazuko Asada, Chie Sotozono, Junji Hamuro, Shigeru Kinoshita; Profiles of cytokines in the aqueous humor and serum of bullous keratopathy patients. Invest. Ophthalmol. Vis. Sci. 2016;57(12):898.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : We are currently developing novel form of regenerative medicine for bullous keratopathy (BK) involving cultivated human corneal endothelial cells (HCECs). Although transplanted cells hold promise for treating BK by ‘seeding’ corneal endothelium, the regenerative ability of injected cells would be influenced by the anterior chamber (AC) milieu. The purpose of this study was to examine cytokine profiles in the aqueous humor (AH) and serum of BK patients to elucidate the contribution of AC milieu to a successful surgical outcome.

Methods : Serum was obtained from BK patients before and after undergoing cell therapy. AH samples were obtained at the start of the surgical procedure from patients undergoing cell-injection therapy or Descemet's stripping automated endothelial keratoplasty (DSAEK). Bio-Plex® Multiplex Immunoassay (Bio-Rad Laboratories) was used to measure the concentrations of 27 cytokines.

Results : IL-1ra, IL-6, IL-7, IL-8, IL-10, IL-12, IL-15, bFGF, Eotaxin, G-CSF, GM-CSF, IFN-γ, IP-10, MCP-1, MIP-1β, RANTES, TNF-α, and VEGF were detected in all AH samples. AH cytokine levels from BK patients before cellinjection therapy were comparable to those from BK patients before DSAEK. Cytokine profiles were classified into 3 distinct patterns: 1) increment of GM-CSF alone, 2) increment of GM-CSF and MCP-1, and 3) increment of GM-CSF, MCP-1, and MIP-1β. RANTES, TNF-α, and VEGF were elevated in 6 BK patients before cell injection, indicating ongoing low-level persistent inflammation in the AC of BK patients. Variation in serum cytokine levels was also found among BK patients before surgery. Our recent findings revealed that cultivated HCECs are composed of diverse subpopulations in regard to the expression of CD44. Different patterns of periodical changes of serum cytokines were observed between cell therapy with CD44- and CD44+ cultivated HCECs. Serum cytokine levels were elevated and remained high for 2 weeks post injection of CD44+ cultivated HCECs, while little changes were confirmed post injection of CD44- cultivated HCECs. Serum cytokine levels were recovered in 2 months in all cases.

Conclusions : AH cytokines might be biomarkers to reveal BK pathogenesis. CD44- fully differentiated cultivated HCECs may not perturb cytokine milieu in AH post cell-injection therapy, and the absence of local inflammation might be linked to successful survival of the injected cells.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×